With the power of a supercomputer, the iPhone is going to be the host for a wide range of healthcare-related consumer devices and related apps. The latest comes from a San Diego startup named Cue. The company has developed a compact consumer-oriented device that can detect five biological conditions at a molecular level. This is not a fitness tracker. To the contrary, the compact and simplistic looking device is a mini-laboratory that has been years in the making. With a simple nasal swab and insertion into the Cue device, the biological data is transferred to your iPhone and then compared with data from the Cue cloud to determine recommended dietary or other actions (see Cue health tracker brings molecular-level testing to iOS).
When Cue launches next year, it will have five tests available :
The cue can detect the level of C-reactive protein (CRP), a commonly used marker of inflammation. Based on the level of the CRP, a consumer may get suggestions on how to optimize workouts, recovery, and a healthy heart.
- Vitamin D
Vitamin D, often called the “sunshine vitamin”, is a hormone produced by the body when the skin absorbs sunlight. Cue suggestions might include spending more or less time in the sun to achieve well-balanced health.
Cue says that tracking the detected level of Luteinizing Hormone (LH) is the best tool to determine the ideal time to conceive a child. The device helps you track the LH level as an indicator of fertility trends, and Cue can recommend food choices that are claimed to support fertility. Cue will provide alerts when LH is at an optimum time for conception.
Cue detection of flu can enable getting an early warning that can enable you to see a doctor early and get an appropriate treatment started.
Testosterone is a hormone that is essential for health and well-being as well as the prevention of osteoporosis. Cue claims its recommendations can help you plan exercise, training, and diet that can boost your natural testosterone levels.
The Cue device is expected to retail for $300 next year. It is considered a “consumer health product” at this stage, but the company is hoping for an FDA approval to enable the device to join the growing list of consumer medical devices.
1 Bassil, Nazem, Saad Alkaade, and John E Morley. “The Benefits and Risks of Testosterone Replacement Therapy: A Review.” Therapeutics and Clinical Risk Management 5 (2009): 427-48.
. . . other recent posts from the category “Healthcare”
- 2015-03-28 – Genesys XXI
- 2015-03-28 – Genesys XXI – Continued
- 2015-03-26 – Health Attitude Launched at Venture Dinner in New York
- 2015-01-30 – Health Attitude Tagline
- 2015-01-24 – Genesys XXI – Coming Soon